Lupin to train over 1,000 graduates for pharma industry
Mumbai-based Lupin expects to train more than 1,000 under graduates into pharma professionals by the year 2020 under its ‘Learn and Earn Initiative’.
Under this initiative, candidates who have passed Standard 12 in the science stream with a minimum of 50 per cent marks but are facing financial constraints, are taken for three-year-long course during which they are paid stipend and provided all facilities.
According to Mr. Yashwant Mahadik, President, Global Human Resource, Lupin, the programme was conceptualised in 2010 due an acute shortage of skilled manpower. “Historically, Lupin was recruiting 1,000 plus fresh graduates every year with no relevant job skill, and sensed that there was a need of job-ready graduates with appropriate technical and life skills,” he said.
Mr. C. Srinivasalu, Senior Vice President (HR), Lupin, informed that since 2011 the company has helped create a total of 560 graduates with 181 students passing out in 2018. “We expect to graduate more than 1,000 students by 2020 adding to the manpower resource of the pharmaceutical sector,” he said.
The company has initiated the ‘Learn and Earn Initiative’ at its facilities in Goa, Tarapur (Maharashtra), Indore (MP), Aurangabad (Maharashtra) and Sikkim, he added.
During the course period, the candidate undergoes five days on-the-job training with one day of classroom session. Further, the students have to compulsorily work with Lupin for two years, after completing their course before they have their options open to join any other pharmaceutical firm.
Lupin has estimated that by the year 2020 it would be spending almost Rs. 20-crore on this programme. This programme will bridge the manpower requirement of pharmaceutical sector in a big way, said Mr. Srinivasalu.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Korea Unlocks Additive Flexibility: New Rules Broaden Food Ingredient Horizons
-
Japan Tightens Tap: Pesticide Limits in Drinking Water Get a Safety Overhaul
-
Uganda Sets Sugar Standards: East African Drafts Define Sweetness and Safety
-
Thailand Clears the Path for Vitamin Use: Streamlined Approval for Supplements
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
Wacker Under Global Cost Pressure: Dual-Track Restructuring Through Layoffs, Consolidation, and Strategic Repositioning
-
Saudi Aramco Weighs Discounts of Up to $9/Barrel on Oman STS Crude as Freight Costs Surge
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
Recommend Reading
-
Iran Closes Strait of Hormuz to All Vessels: Global Chemical Trade Gets Choked
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
February Hydrogen Peroxide Market Trends Weaken and Decline
-
Insufficient Downstream Demand, DMF Prices Remain Stable
-
Coke Market Prices Remain Stable for Now
-
Sodium Hydroxide Price Increase on February 25
-
Cost-Driven Restart, Supply-Demand Resonance Drives Acrylic Prices Higher